State Pharmaceutical Assistance for GLP-1

By Insurance Review Editorial ·

State Pharmaceutical Assistance for GLP-1

The landscape around state pharmaceutical assistance for glp 1 continues to evolve as new studies emerge and treatment protocols improve. This article captures the most up-to-date thinking on the subject.


Plan Details

Our research of this insurance product indicates notable details for patients seeking Ozempic or Wegovy:


What You Will Pay

Estimating what you will pay involves considering several variables:

| Element | Typical Range | |---|---| | Drug copay | $25-150 | | Deductible applies | Often yes | | Yearly cap | $3,000-8,000 | | Copay assistance | Check eligibility |

Once you reach your annual deductible, many plans shift to cost-sharing ranging from 20-50% before you meet the yearly cap.


Getting Your Medication Approved

  1. Check your formulary — Search medication coverage by contacting your plan
  2. Get doctor documentation — Your doctor needs to document the clinical rationale including health conditions and step therapy history
  3. Submit prior auth — Your doctor’s office sends the prior authorization to the PBM
  4. Challenge denials — If denied, there is the right to appeal the refusal — approval on appeal are surprisingly high

Our Verdict

Considering the overall package, ease of access, and patient cost, we rate this option for GLP-1 access:


Frequently Asked Questions

Does this plan cover Ozempic?

The answer depends on the specific plan tier and your specific reason for taking it. Diabetes diagnoses are usually approved versus weight management prescriptions.

What if my prior authorization is denied?

Appeal the decision immediately. Include supplemental records from your healthcare provider. A large percentage succeed upon review with adequate medical evidence.